Woman in desperate need of prescription drug being investigated as COVID-19 treatment

Click here for updates on this story

    LAWRENCE, Kan. (WDAF) — A Lawrence woman is caught between the fight for a possible treatment for COVID-19 and a drug she desperately needs for her autoimmune issues.

Nancy Pistorius says her rheumatologists have prescribed the drug hydroxychloroquine for years and never, until now, had any troubling find what she considers a life-saving medication.

“My pharmacist told me she couldn’t refill my prescription because of a nationwide shortage of this drug,” Pistorius told FOX4. “She said it may take months to get more because there’s a complete national shortage and none in the warehouse.”

“I was flabbergasted when my pharmacist said she couldn’t get one of my most important drugs. I just couldn’t believe it.”

The freelance writer said her health will deteriorate without the daily medication.

“I will have widespread inflammation and pretty soon I may not be able to walk,” she said. “And it could affect other organs in my body.

“I see two different rheumatologists – one at The Mayo Clinic and KU (The University of Kansas Health System),” added Pistorius, who also has autoimmune rheumatoid arthritis. “Both said I need this drug.”

Hydroxychloroquine and chloroquine are used to treat malaria, lupus, rheumatoid arthritis, and other diseases. The Food and Drug Administration, however, just issued an emergency use authorization for the drugs to treat patients hospitalized with coronavirus or for use in clinical trials.

The FDA’s decision on Sunday came as a surprise to Pistorius, who worries the action could trigger even more shortages.

“It was a bombshell,” she said.

Although hydroxychloroquine and chloroquine are not approved treatments for COVID-19, the FDA said in a statement: “Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients.”

But the agency added this caveat: “Clinical trials are needed to provide scientific evidence that these treatments are effective.”

The FDA said the 30 million doses of donated hydroxychlorquine and one million doses of donated chloroquine will be placed in the Strategic National Stockpile (SNS) and distributed and prescribed by doctors to “hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”

The FDA also said its action should alleviate, not accelerate, shortages of the drugs.

“Use of the donated medications is expected to help ease supply pressures for the drug,” the agency said in a statement.

Pistorius is cautiously optimistic about the FDA’s prediction.

“I hope it’s true that it will ease the demand — so that once hospitals have what they need for COVID-19 patients — there will be some left over for people who need it for their health issues.”

“I feel so sorry for the people who get that terrible disease,” she added. “And I don’t want people to die because they don’t have the drugs they need. But I’m skeptical that this is the drug they need. I’ve only seen anecdotal research (that these drugs are a possible cure for COVID-19).”

The FDA also said it’s also working with manufacturers of hydroxychloroquine and chloroquine to increase production of the drugs.

That move can’t come soon enough for Pistorius.

“I think the manufacturers (of those drugs) owe something to the people who have been taking it all along and need it badly for their health issues,” she said, adding she’s frustrated by reports that many people obtained prescriptions for the drugs because of rumors the medications could prevent COVID-19.

She blames those people, and those misleading reports, for the current drug shortages.

“I don’t understand the people taking them as a prophylactic (to prevent the disease),” she said.

Several state and national medical boards echoed her concerns. The Missouri State Board of Registration for the Healing Arts and the Missouri Board of Pharmacy said last week it had received reports about an uptick in the number of prescriptions for the drugs for “prophylactic purposes” amid the COVID-19 pandemic.

“Concerns have been raised that this activity may lead to stockpiling of medication, inappropriate use and potential drug shortages for patients with a legitimate need,” the boards said in a joint press release. “Prescribers should exercise caution and refrain from prophylactic prescribing in light of the State of Emergency.”

The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists also warned the drugs must be written only for legitimate medical reasons.

“We are aware that some physicians and others are prophylactically prescribing medications currently identified as potential treatments for COVID-19 (e.g., chloroquine or hydroxychloroquine, azithromycin) for themselves, their families, or their colleagues,” the associations said in a joint statement. “And that some pharmacies and hospitals have been purchasing excessive amounts of these medications in anticipation of potentially using them for COVID-19 prevention and treatment. We strongly oppose these actions.”

In the meantime, Pistorius continues to search for her much-needed medications.

“I was on the phone for almost two hours last night with one pharmacy,” she said Tuesday. “I found a pharmacy in Blue Springs that has some and I hope they’ll deliver to Lawrence.”

“I know I’m not the only one impacted by this,” added Pistorius, who said her next step is check online pharmacies. “There are a lot of other people in the same boat. But I only have 10 pills left.”

Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.